u/janek_ferrari

area% is not mass%, and here is exactly why it matters

interval stretching versus dose reduction

the concentration on the vial in marker is the most important step

ALT is where the fatty-liver story shows up first

The single most useful thing I did was write the concentration on the vial. Stopped all the confusion after that.

Yeah, showing the arithmetic is the fastest way for someone to spot the error.

Yeah, 96.8% area is not the problem, the missing impurity breakdown is the problem.

cite the discontinuation data rather than guessing regain rates

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Same lab both times?

the method line is doing real work, not just window dressing

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

the related substances line is where the story is

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

The confident tone is doing a lot of work that the evidence is not.

Not to be pedantic but TRIUMPH and retatrutide are being used interchangeably and they are not interchangeable in real life.

The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.

Yeah, regain is not a failure.

A1c moves slowly, quarterly is plenty

Half-life is about 168 hours, so steady state lands around week 19–5. Practical consequence: what you feel in week 1 is not what that dose does.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

the method line is doing real work, not just window dressing